These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22774994)

  • 21. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
    Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
    J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance.
    Watanabe M; Yamashita K; Kamachi H; Kuraya D; Koshizuka Y; Shibasaki S; Asahi Y; Ono H; Emoto S; Ogura M; Yoshida T; Ozaki M; Umezawa K; Matsushita M; Todo S
    Transplantation; 2013 Sep; 96(5):454-62. PubMed ID: 23860082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosensitization of islet allograft recipients.
    Cardani R; Pileggi A; Ricordi C; Gomez C; Baidal DA; Ponte GG; Mineo D; Faradji RN; Froud T; Ciancio G; Esquenazi V; Burke GW; Selvaggi G; Miller J; Kenyon NS; Alejandro R
    Transplantation; 2007 Dec; 84(11):1413-27. PubMed ID: 18091517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
    Giovannoni L; Muller YD; Lacotte S; Parnaud G; Borot S; Meier RP; Lavallard V; Bédat B; Toso C; Daubeuf B; Elson G; Shang L; Morel P; Kosco-Vilbois M; Bosco D; Berney T
    Transplantation; 2015 Jan; 99(1):29-35. PubMed ID: 25340601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.
    Hering BJ; Kandaswamy R; Ansite JD; Eckman PM; Nakano M; Sawada T; Matsumoto I; Ihm SH; Zhang HJ; Parkey J; Hunter DW; Sutherland DE
    JAMA; 2005 Feb; 293(7):830-5. PubMed ID: 15713772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation.
    Bestard O; Cruzado JM; Lucia M; Crespo E; Casis L; Sawitzki B; Vogt K; Cantarell C; Torras J; Melilli E; Mast R; Martinez-Castelao A; Gomà M; Reinke P; Volk HD; Grinyó JM
    Kidney Int; 2013 Dec; 84(6):1226-36. PubMed ID: 23783240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-clinical results in pig-to-non-human primate islet xenotransplantation using anti-CD40 antibody (2C10R4)-based immunosuppression.
    Shin JS; Kim JM; Min BH; Yoon IH; Kim HJ; Kim JS; Kim YH; Kang SJ; Kim J; Kang HJ; Lim DG; Hwang ES; Ha J; Kim SJ; Park WB; Park CG
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitomycin C treatment improves pancreatic islet graft longevity in intraportal islet transplantation by suppressing proinflammatory response.
    Yamane K; Anazawa T; Tada S; Fujimoto N; Inoguchi K; Emoto N; Nagai K; Masui T; Okajima H; Takaori K; Sumi S; Uemoto S
    Sci Rep; 2020 Jul; 10(1):12086. PubMed ID: 32694579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial.
    Roemhild A; Otto NM; Moll G; Abou-El-Enein M; Kaiser D; Bold G; Schachtner T; Choi M; Oellinger R; Landwehr-Kenzel S; Juerchott K; Sawitzki B; Giesler C; Sefrin A; Beier C; Wagner DL; Schlickeiser S; Streitz M; Schmueck-Henneresse M; Amini L; Stervbo U; Babel N; Volk HD; Reinke P
    BMJ; 2020 Oct; 371():m3734. PubMed ID: 33087345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAK3 inhibitor-based immunosuppression in allogeneic islet transplantation in cynomolgus monkeys.
    Kim JM; Shin JS; Min BH; Kang SJ; Yoon IH; Chung H; Kim J; Hwang ES; Ha J; Park CG
    Islets; 2019; 11(5):119-128. PubMed ID: 31483188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models.
    McGuire HM; Walters S; Vogelzang A; Lee CM; Webster KE; Sprent J; Christ D; Grey S; King C
    Diabetes; 2011 Mar; 60(3):867-75. PubMed ID: 21357471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppression in islet transplantation.
    Van Belle T; von Herrath M
    J Clin Invest; 2008 May; 118(5):1625-8. PubMed ID: 18431511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells.
    Oluwole OO; Depaz HA; Gopinathan R; Ali A; Garrovillo M; Jin MX; Hardy MA; Oluwole SF
    Diabetes; 2001 Jul; 50(7):1546-52. PubMed ID: 11423475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation.
    Hafiz MM; Faradji RN; Froud T; Pileggi A; Baidal DA; Cure P; Ponte G; Poggioli R; Cornejo A; Messinger S; Ricordi C; Alejandro R
    Transplantation; 2005 Dec; 80(12):1718-28. PubMed ID: 16378067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.